Disclosure
This article contains an affiliate link. Nutrafol runs an affiliate programme we participate in, and we may earn a commission if you buy through our link. Nutrafol is a dietary supplement, not a medicine — it is not FDA-approved to treat hair loss, and nothing here should be read as saying it treats anything described below. Read our full affiliate disclosure.
This page is informational only and is not medical advice.
The short version
It is in the trial data: 5.4% of tirzepatide users reported hair loss against 0.9% on placebo, and around 3% versus 1% for semaglutide.
The higher rate on the drug that produces more weight loss is the clue. This is telogen effluvium — a temporary shift in the hair cycle triggered by rapid weight loss — not damage from the molecule.
It appears two to three months after the trigger and usually resolves over six to twelve months once weight stabilises. Protein, micronutrients and pace are the levers.
How Common It Actually Is
For a long time this was dismissed as anecdote. It is not — it is in the trials, and the difference between the two drugs is the most informative part.
- Semaglutide. In trials of semaglutide for weight management, around 3% of participants reported hair loss, against about 1% on placebo.
- Tirzepatide. Across the SURMOUNT programme, hair loss affected 5.4% of tirzepatide users — 119 of 2,183 — against 0.9% on placebo, 22 of 2,221.
- Real-world data agrees. A cohort study published in the Journal of the American Academy of Dermatology in 2026 found semaglutide and tirzepatide use associated with significantly increased risk of anagen effluvium, telogen effluvium, androgenetic alopecia, alopecia areata and other non-scarring hair loss.
- Pharmacovigilance agrees too. A ten-year review of FDA adverse event reports flagged alopecia signals for both drugs.
So: uncommon, clearly above placebo, and about five times more often reported on tirzepatide than on semaglutide. Hold that last fact, because it is the one that tells you what is actually going on.
It Is Almost Certainly the Weight Loss, Not the Drug
Tirzepatide has the higher rate. Tirzepatide also produces the most weight loss of any approved option. Those two things moving together is what you would expect if the shedding were driven by the magnitude and speed of weight loss rather than by anything the molecule does to a follicle — and reviews looking at this have noted that tirzepatide is most frequently linked with telogen effluvium specifically.
Telogen effluvium is a well-characterised response, not a mystery. Hair follicles cycle between a growth phase and a resting phase, normally out of step with one another. A significant physiological stressor pushes an unusually large share of them into the resting phase at the same time, and two to three months later they shed together. That is why people report losing up to around 300 hairs a day against a usual figure of roughly 100.
The list of things that trigger it is instructive: major surgery, serious illness, childbirth, high fever, severe emotional stress — and rapid weight loss. It is well documented after bariatric surgery and after crash dieting, entirely without any medication involved. The risk rises with how fast and how severe the calorie deficit is, and with any nutritional shortfall alongside it.
Why this framing matters
If the shedding were drug toxicity, the only lever would be stopping the drug. Because it is a stress response to the rate of weight loss, you have several levers that do not involve giving up the treatment: protein intake, micronutrient status, and how fast you escalate.
It also means the timeline is predictable. In the large majority of cases hair returns to its usual density over roughly six to twelve months once weight stabilises. The follicles are resting, not gone.
The Levers You Actually Have
- Protein, first and by some distance. Hair is keratin, a protein. When intake is short the body allocates what it has to organs rather than hair. Eating enough protein is difficult when your appetite has collapsed, which is exactly why this is the most common shortfall — see our guide to protein and satiety.
- Micronutrients, particularly iron, zinc and vitamin D. All three are associated with hair shedding when low, and all three are worth attending to on a GLP-1 regardless — our piece on nutrient deficiencies on a GLP-1 covers what the monitoring picture looks like. Get tested rather than guessing; supplementing iron you do not need is its own problem.
- Pace. If you are losing very fast, that is the stressor. Raise it with your prescriber — a slower titration is a legitimate option, and one that keeps the treatment.
- Patience with the lag. What you are shedding today reflects what your body was doing two to three months ago. If you fixed your protein intake last week, you will not see the benefit for months, and the shedding continuing in the meantime does not mean it did not work.
- Do not stack another deficit on top. Adding an aggressive diet to a GLP-1 compounds the trigger rather than speeding anything useful up.
When It Is Not Telogen Effluvium
Diffuse shedding from all over the scalp, two to three months after starting or escalating, is the classic picture. Some things do not fit that picture and are worth a clinician rather than a supplement.
- Discrete round patches. That pattern suggests alopecia areata, which is autoimmune and treated differently. The 2026 cohort study found an increased association with it too.
- A receding hairline or thinning crown. That is androgenetic pattern loss. Weight loss can make it more visible, but it is a separate, progressive condition with its own treatments — and it does not resolve on its own the way telogen effluvium does.
- Redness, scaling, pain or itching. Scalp symptoms point elsewhere, and scarring alopecias need prompt attention because the follicle loss is permanent.
- Shedding that has not improved a year after your weight stabilised. That is outside the expected course and warrants investigation, including thyroid and iron studies.
Supplements: What They Can and Cannot Do
Here is the awkward structural problem with judging any hair supplement in this situation: telogen effluvium resolves on its own in the large majority of cases over six to twelve months. Anyone who starts a supplement partway through and recovers will reasonably credit the supplement. That is not evidence, and it is why the category thrives.
Nutrafol is the best-known product here and has more behind it than most. Its Core for Women formula is a four-capsule daily supplement built around a blend including Sensoril ashwagandha, saw palmetto, marine collagen peptides, curcumin and a tocotrienol complex. It publishes a real trial: a six-month randomised, double-blind, placebo-controlled study in the Journal of Drugs in Dermatology reported significant increases in terminal and vellus hair counts at day 90 and day 180 versus placebo, with blinded investigator assessments showing improvements in growth and quality, and no reported adverse events.
Read that with two things in mind. The trial had 40 participants — 26 active and 14 placebo — which is small. And it studied perimenopausal and menopausal women with self-perceived thinning hair, which is a different population and a different mechanism from weight-loss-triggered telogen effluvium. It is genuine evidence for what it tested. It is not evidence for the situation this article is about.
Before you buy
If your shedding is driven by a protein or micronutrient shortfall, fixing that is upstream of any supplement and costs less. Get iron, ferritin, zinc and vitamin D checked first — a supplement cannot tell you which of those is low, and a blood test can.
Two specific cautions on the formula: it contains marine collagen, so it is not suitable if you have a fish or shellfish allergy, and saw palmetto has hormonal activity that makes it inappropriate in pregnancy or when trying to conceive. Anyone on prescription medication — which, reading this, you are — should run the ingredient list past a pharmacist or prescriber.
On price: Nutrafol Core for Women is $79 a month on subscription against a $88 list price, with three months at $224 and six at $422. Directions are four capsules once a day, and the company sets expectations at “results in 3–6 months”. It offers results in six months or your money back, with conditions worth knowing before you rely on them: you must buy six bottles on subscription within 180 days, take the capsules daily, and submit monthly progress photos. That is a real guarantee with real paperwork attached, not a slogan.
Dietary supplement · Not a treatment for telogen effluvium · Check bloods first
What we would actually do
- Get bloods: ferritin, iron studies, zinc, vitamin D, thyroid function.
- Hit a protein target every day, deliberately, whether or not you feel like eating.
- Raise the pace of weight loss with your prescriber if it is very fast.
- Expect the lag. Judge progress at three months, not three weeks.
- See a clinician for patchy loss, scalp symptoms, or a receding hairline.
- Treat a supplement as the last item on this list, not the first.
Frequently Asked Questions
How common is hair loss on a GLP-1?
Uncommon but clearly above placebo, and higher on tirzepatide than semaglutide. In trials of semaglutide for weight management, around 3% of participants reported hair loss against 1% on placebo. Across the SURMOUNT tirzepatide trials the figures were 5.4% (119 of 2,183) versus 0.9% on placebo (22 of 2,221). Real-world work points the same way: a cohort study published in the Journal of the American Academy of Dermatology in 2026 found semaglutide and tirzepatide use associated with a significantly increased risk of several kinds of non-scarring hair loss, and a ten-year review of FDA adverse event reports flagged alopecia signals for both drugs.
Is the medication causing it, or the weight loss?
The pattern strongly suggests the weight loss. Tirzepatide has roughly five times the reported rate of semaglutide, and tirzepatide is also the drug that produces the most weight loss — the two track together. What is being described is telogen effluvium, a well-recognised response in which a physiological stressor pushes an unusually large share of hair follicles into their resting phase at once. It happens after bariatric surgery, after crash dieting, after illness, childbirth and major surgery. Rapid weight loss is simply another trigger, and these medications are very good at producing rapid weight loss.
When does it start and when does it stop?
The lag is the thing nobody expects. Telogen effluvium typically appears two to three months after the trigger, so the shedding you are seeing now reflects what your body was doing in the spring. Daily loss can reach around 300 hairs against a normal 100 or so. In the large majority of cases it resolves: hair generally returns to its usual density over roughly six to twelve months once weight stabilises and nutrition is adequate. It is a shift in the growth cycle, not destruction of the follicle.
What actually helps?
Three things, in order of how much evidence sits behind them. Eat enough protein — hair is keratin, and when protein is short the body prioritises organs over hair. Address micronutrient shortfalls, particularly iron, zinc and vitamin D, which is worth doing on a GLP-1 anyway. And consider the pace: if you are losing very fast, discuss the titration schedule with your prescriber, because the risk rises with the speed and severity of the deficit. None of that is exciting, and all of it is upstream of any supplement.
Should I stop my medication because of hair loss?
That is a conversation with your prescriber, not a decision to make alone, and for most people the answer is no. Telogen effluvium is temporary and self-limiting in the large majority of cases, while the metabolic benefits of treatment are not. What is reasonable to discuss is pace — a slower titration means slower weight loss, which means less of the stressor driving the shedding. Stopping outright trades a temporary, reversible problem for the return of a permanent one.
Do hair supplements work for this?
Some have real trial data behind them, but almost none of it is in this population. Nutrafol, the best-known example, has a six-month randomised double-blind placebo-controlled study published in the Journal of Drugs in Dermatology showing significant increases in terminal and vellus hair counts — but with 40 participants total, and in perimenopausal and menopausal women with self-perceived thinning, which is a different problem from weight-loss-triggered telogen effluvium. Add to that the awkward fact that telogen effluvium resolves on its own in most cases over six to twelve months, which makes it very easy to credit a supplement for recovery that was going to happen anyway.
Where to Go Next
- Nutrient deficiencies on a GLP-1 — the iron, zinc and vitamin D picture behind most of this
- Muscle loss on a GLP-1 — the other thing rapid loss takes from you, and what protects it
- Ozempic face — the other appearance change nobody warns you about
Medical Disclaimer
We're not doctors, and this article is for education only — it isn't medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. Individual results vary widely, and only a clinician who knows your history can determine what is safe and appropriate for you. See our full medical disclaimer.
Keep Comparing
Every provider we've researched, with published pricing, medication type, and what's actually included.
Affiliate Disclosure: This article may contain affiliate links. If you sign up through one, we may earn a commission at no additional cost to you. We do not accept payment for favorable coverage. Read our full affiliate disclosure policy.